SCHEMBL318966

SCHEMBL318966

Cc1[c]cnc(C)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4924782 0.76
SCHEMBL8941078 0.74
SCHEMBL907735 0.74
SCHEMBL1859032 0.74
SCHEMBL6661278 0.74
SCHEMBL452030 0.74
SCHEMBL596463 0.74
SCHEMBL4922063 0.74
SCHEMBL3135272 0.74
SCHEMBL4930532 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 316 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024115549-A1 ARYL- AND HETEROARYL-SULFONAMIDE DERIVATIVES AS CCR8 MODULATORS IDORSIA PHARMACEUTICALS LTD (CH) 2024-06-06 WO claimed
WO-2015197188-A1 PYRAZOLYL-BASED CARBOXAMIDES AS CRAC INHIBITORS Grünenthal GmbH (DE) 2015-12-30 WO claimed
WO-2015197187-A1 PYRAZOLYL-BASED CARBOXAMIDES V Grünenthal GmbH (DE) 2015-12-30 WO claimed
EP-2918580-A1 PIPERAZINEDIONES AS OXYTOCIN RECEPTOR ANTAGONISTS Glaxo Group Limited (GB) 2015-09-16 EP claimed
WO-2015090579-A1 PYRAZOLYL-BASED CARBOXAMIDES IV Grünenthal GmbH (DE) 2015-06-25 WO claimed
WO-2015090580-A1 PYRAZOLYL-BASED CARBOXAMIDES USEFUL AS CALCIUM RELEASE ACTIVATED CALCIUM CHANNEL (ICRAC) INHIBITORS Grünenthal GmbH (DE) 2015-06-25 WO claimed
US-20150166505-A1 PYRIDINYL-SUBSTITUTED PYRAZOLYL CARBOXAMIDES Grünenthal GmbH (DE) 2015-06-18 US claimed
US-8742099-B2 Compounds GLAXO GROUP LIMITED (GB) 2014-06-03 US claimed
CN-101495464-B Prokineticin 1 receptor antagonists JANSSEN PHARMACEUTICA NV 2014-03-05 CN claimed
CN-103396398-A Prokineticin 1 receptor antagonists JANSSEN PHARMACEUTICA NV 2013-11-20 CN claimed
WO-1999038868-A1 AZOLO TRIAZINES AND PYRIMIDINES DU PONT PHARMACEUTICALS COMPANY (US) 1999-08-05 WO claimed
EP-0112707-B1 AMINOPYRIMIDINONE DERIVATIVES AS HISTAMINE H1-ANTAGONISTS SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1987-11-04 EP claimed
EP-0134091-B1 PYRIMIDONE DERIVATIVES SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1987-06-16 EP claimed
US-4665078-A RHINITIS, HAY FEVER, ASTHMA, ECZEMA SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1987-05-12 US claimed
EP-0068833-B1 PYRIMIDINONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1986-10-15 EP claimed
US-4548940-A Pyridylaminoalkylaminopyrimidones useful as histamine H1 -antagonists SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1985-10-22 US claimed
EP-0134091-A1 Pyrimidone derivatives SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1985-03-13 EP claimed
US-4486434-A PYRIDYLALKYLAMINO PYRIDYLMETHYL PYRIMIDONES SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1984-12-04 US claimed
EP-0112707-A2 Aminopyrimidinone derivatives as histamine H1-antagonists SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1984-07-04 EP claimed
EP-0068833-A2 Pyrimidinone derivatives and pharmaceutical compositions containing them SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1983-01-05 EP claimed